NCT06552767View on ClinicalTrials.gov

Thrombosis and Inflammation in Vessels Initiative (TIVI)

RecruitingOBSERVATIONAL
Enrollment

1,000

Participants

Timeline

Start Date

November 22, 2024

Primary Completion Date

January 30, 2034

Study Completion Date

January 30, 2034

Conditions
Cardiovascular DiseasesVascular Diseases
Trial Locations (1)

20892

RECRUITING

National Institutes of Health Clinical Center, Bethesda

All Listed Sponsors
lead

National Heart, Lung, and Blood Institute (NHLBI)

NIH

NCT06552767 - Thrombosis and Inflammation in Vessels Initiative (TIVI) | Biotech Hunter | Biotech Hunter